Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biologics
Filter
Filter
Sort By
Newest First
Sector
Service / Activity
Reset
1 / 30
1 / 30
CDMO
Enhancing Biopharmaceutical Stability Through Lyophilization
David King; Hoju Lee; Sungjin Park; Yeonju Yoon
Samsung Biologics
PAO-11-24-CL-08
Nov 26, 2024
Financing
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
EQT
PR-11-24-NI-116
Nov 20, 2024
Clinical Trials
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
Concerto Biosciences
PR-11-24-NI-112
Nov 19, 2024
Technology
Building the Future of E. coli Biomanufacturing with Protein Secretion
Trond Erik Vee Aune, Ph.D.; Jostein Malmo, Ph.D.; Dominik Bahiense de Mello
Vectron Biosolutions
PAO-11-24-CL-07
Nov 18, 2024
Biotherapeutics
Building on Australia's Existing Biopharma Infrastructure
BIoCina
PAO-11-24-RTM-07
Nov 15, 2024
ADC
Chime Biologics and Waterstone Jointly Develop and Manufacture Antibody-Drug Conjugate (ADC)
Chime Biologics
PR-10-24-NI-91
Nov 12, 2024
Biomanufacturing
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
Ginkgo Bioworks
PR-10-24-NI-92
Nov 12, 2024
Biomanufacturing
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Aaron B. Cowley, Ph.D.
Arranta Bio
PAO-11-24-CL-04
Nov 11, 2024
Large Molecule
Johnson & Johnson submits applications seeking approval as subcutaneous monotherapy for high-risk smoldering multiple myeloma
Johnson & Johnson
PR-10-24-NI-88
Nov 08, 2024
Announcement
Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement
World ADC
PR-10-24-NI-77
Nov 08, 2024
Antibodies
Reshaping the Approach to Therapeutic Development with i-Bodies
AdAlta
PAO-10-24-RTM-12
Nov 06, 2024
Biomanufacturing
Olon is Ready to Host Productions in the New Facility Dedicated to Ultra-Potent Compounds
Olon
PR-10-24-NI-72
Nov 04, 2024
QbD
Designing Quality into Biomanufacturing
Miguel Carrion; Michelle Kneeland
Tanvex CDMO
PAO-10-24-CL-09
Oct 29, 2024
Fill/Finish
Superior Performance of SaniSure® Pharm-A-Clear LH® Tubing in Extended Fill/Finish Applications
Alex Van Hagen, Ph.D.; Nicholas Brust
Sanisure
PAO-08-24-CL-10
Oct 29, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13
Oct 25, 2024
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38
Oct 11, 2024
CDMO
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Janet Hoogstraate, Ph.D.
NorthX Biologics
PAO-10-24-CL-07
Oct 07, 2024
Financing
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE
Halozyme Therapeutics
PR-09-24-NI-31
Oct 04, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07
Sep 30, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09
Sep 30, 2024
